Healthcare -
Biotechnology - NASDAQ - US
$ 21.4
3.68 %
$ 1.9 B
Market Cap
-5.26
P/E
TVTX - STOCK-BASED COMPENSATION
Stock-based Compensation TVTX - Travere Therapeutics, Inc.
36.9 M
LAST VALUE
-1.63%
2 YEAR CAGR
11.83%
5 YEAR CAGR
8.79%
10 YEAR CAGR